HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marco Metra Selected Research

Systolic Heart Failure

1/2021Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
6/2018Effects of ivabradine on endothelial function, aortic properties and ventricular-arterial coupling in chronic systolic heart failure patients.
12/2015Effects of spironolactone on ventricular-arterial coupling in patients with chronic systolic heart failure and mild symptoms.
1/2015Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation.
8/2013Risk following hospitalization in stable chronic systolic heart failure.
7/2003Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marco Metra Research Topics

Disease

455Heart Failure
05/2024 - 02/2002
28Atrial Fibrillation
04/2024 - 07/2005
27COVID-19
11/2023 - 01/2020
20Mitral Valve Insufficiency (Mitral Regurgitation)
02/2024 - 05/2013
20Renal Insufficiency (Renal Failure)
01/2023 - 01/2007
19Dyspnea (Shortness of Breath)
10/2022 - 07/2005
18Myocardial Infarction
04/2024 - 04/2002
18Inflammation (Inflammations)
10/2023 - 10/2016
15Cardiomyopathies (Cardiomyopathy)
02/2024 - 01/2007
15Heart Diseases (Heart Disease)
12/2023 - 03/2012
14Stroke (Strokes)
04/2024 - 02/2005
14Hypertension (High Blood Pressure)
01/2023 - 10/2003
14Iron Deficiencies
01/2023 - 10/2017
11Hypotension (Low Blood Pressure)
03/2024 - 02/2002
11Left Ventricular Dysfunction
01/2022 - 05/2003
10Type 2 Diabetes Mellitus (MODY)
04/2024 - 04/2012
10Acute Coronary Syndrome
01/2023 - 08/2007
10Cardiovascular Diseases (Cardiovascular Disease)
09/2022 - 09/2003
9Cardiogenic Shock
02/2024 - 11/2012
9Hemorrhage
01/2022 - 01/2014
8Disease Progression
04/2024 - 10/2010
8Weight Loss (Weight Reduction)
12/2023 - 05/2013
8Chronic Renal Insufficiency
10/2022 - 02/2008
7Acute Kidney Injury (Acute Renal Failure)
04/2024 - 04/2015
7Anemia
11/2023 - 03/2012
7Edema (Dropsy)
11/2023 - 11/2007
7Diabetes Mellitus
01/2021 - 12/2003
7Coronary Artery Disease (Coronary Atherosclerosis)
01/2021 - 04/2002
6Obesity
04/2024 - 01/2007
6Neoplasms (Cancer)
12/2023 - 11/2018
6Fibrosis (Cirrhosis)
11/2023 - 06/2014
6Chronic Obstructive Pulmonary Disease (COPD)
11/2023 - 05/2013
6Necrosis
10/2023 - 01/2020
6Amyloidosis
09/2023 - 12/2022
6Infections
06/2022 - 02/2016
6Thrombosis (Thrombus)
03/2022 - 09/2008
6Systolic Heart Failure
01/2021 - 07/2003
5Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve)
01/2024 - 12/2020
5Myocarditis (Carditis)
11/2023 - 06/2020
5Cardiac Sudden Death (Sudden Cardiac Arrest)
11/2023 - 02/2009
5Body Weight (Weight, Body)
01/2023 - 01/2007
5Cardio-Renal Syndrome
02/2018 - 09/2005

Drug/Important Bio-Agent (IBA)

65Brain Natriuretic Peptide (Natrecor)FDA Link
12/2023 - 12/2003
55Biomarkers (Surrogate Marker)IBA
12/2023 - 08/2007
33pro-brain natriuretic peptide (1-76)IBA
03/2024 - 08/2007
25Natriuretic PeptidesIBA
04/2024 - 09/2003
22TroponinIBA
02/2024 - 08/2007
22DiureticsIBA
11/2023 - 07/2003
19rolofyllineIBA
11/2019 - 10/2008
18CreatinineIBA
03/2024 - 01/2012
18Carvedilol (Coreg)FDA LinkGeneric
02/2010 - 02/2002
17Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2022 - 05/2003
17Metoprolol (Toprol-XL)FDA LinkGeneric
11/2007 - 02/2002
16Mineralocorticoid Receptor AntagonistsIBA
03/2024 - 09/2004
16omecamtiv mecarbilIBA
01/2024 - 03/2016
15SodiumIBA
04/2024 - 05/2013
14RelaxinIBA
01/2023 - 04/2009
13ferric carboxymaltoseIBA
01/2023 - 10/2017
11Glucose (Dextrose)FDA LinkGeneric
11/2023 - 08/2007
11Angiotensin Receptor AntagonistsIBA
11/2022 - 09/2004
11sacubitril and valsartan sodium hydrate drug combinationIBA
04/2022 - 09/2018
11Urea (Carbamide)FDA LinkGeneric
01/2017 - 01/2014
10IronIBA
05/2024 - 10/2017
10Sodium-Glucose Transport ProteinsIBA
03/2024 - 01/2021
10Purinergic P1 Receptor AntagonistsIBA
11/2019 - 01/2010
9AnticoagulantsIBA
12/2023 - 09/2008
9Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA
11/2023 - 11/2014
9PotassiumIBA
11/2022 - 09/2015
9NitrogenIBA
01/2017 - 01/2014
8Furosemide (Lasix)FDA LinkGeneric
01/2024 - 02/2008
8Hemoglobins (Hemoglobin)IBA
11/2023 - 05/2013
8Cardiac MyosinsIBA
01/2023 - 03/2016
8Troponin T (Troponin T1)IBA
11/2020 - 08/2007
7Neprilysin (Neutral Endopeptidase)IBA
03/2024 - 10/2017
7Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2011
7Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2011
6Angiotensin Receptors (Angiotensin II Receptor)IBA
03/2024 - 03/2015
6SymportersIBA
11/2023 - 10/2019
6LigandsIBA
11/2023 - 01/2007
6empagliflozinIBA
12/2022 - 10/2019
6ReninIBA
03/2022 - 09/2003
6AldosteroneIBA
03/2022 - 09/2003
6Sodium-Glucose Transporter 2 InhibitorsIBA
01/2022 - 01/2020
6IvabradineIBA
11/2021 - 08/2013
6Adenosine (Adenocard)FDA LinkGeneric
03/2012 - 10/2008
5Amyloid (Amyloid Fibrils)IBA
10/2023 - 01/2022
5CytokinesIBA
09/2023 - 02/2009
5Spironolactone (Aldactone)FDA LinkGeneric
11/2022 - 11/2010
5EnalaprilFDA LinkGeneric
03/2022 - 10/2017
5AngiotensinsIBA
03/2022 - 01/2007
5Growth Differentiation Factor 15IBA
01/2022 - 11/2015
5Endothelin-1 (Endothelin 1)IBA
12/2020 - 07/2005

Therapy/Procedure

181Therapeutics
05/2024 - 02/2002
44Patient Readmission
03/2024 - 01/2010
17Length of Stay
01/2023 - 01/2010
12Heart Transplantation (Grafting, Heart)
01/2024 - 04/2002
10Cardiac Resynchronization Therapy
01/2019 - 01/2007
7Transcatheter Aortic Valve Replacement
04/2024 - 09/2014
5Percutaneous Coronary Intervention
10/2023 - 04/2012
5Palliative Care (Palliative Therapy)
01/2023 - 12/2005